US FDA grants breakthrough therapy designation to Daiichi Sankyo & Merck’s ifinatamab deruxtecan for patients with pretreated extensivestage SCLC: Tokyo Tuesday, August 19, 2025 ...

TS ICET 2025 Phase 1 counselling registration begins August 20 for MBA and MCA admissions in Telangana. Qualified candidates can apply online at icet.tgche.ac.in or tgicet.nic.in by submitting details ...

Beyfortus (nirsevimab) is the only option that can offer RSV protection designed for all infants with proven high, sustained efficacy, favourable safety and public health impact demonstrated in the ...

Can Alabama work around it, get new faces up to speed, mitigate those losses? Can Alabama be more dynamic in the return game?

Viking Therapeutics offers a speculative opportunity, driven by its promising obesity drug pipeline. Click here to read more ...

The money train never stops. The MTA awarded a nearly $2 billion contract on Monday for the long-promised Second Avenue ...

The contract, which will award nearly $2 billion to construction firms, funds crucial aspects of the latest phase of the long ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ifinatamab deruxtecan for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) ...

The string of negative updates from Novo Nordisk and positive news flow from the main competitor Eli Lilly has finally ended ...

The City of Raleigh is set to embark on the first phase of its much-anticipated Bus Rapid Transit (BRT) system, focusing on a ...

FDA designates ifinatamab deruxtecan as a breakthrough therapy for extensive-stage small cell lung cancer, promising improved ...

Russia’s troops are continuing their slow war of attrition in eastern and northern Ukraine, even as the conflict enters a ...